Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro

Journal of Medical Virology

Volumn 85, Issue 1, 2013, Pages 132-137

  Nukuzuma, Souichi ^a   Kameoka, Masanori ^b   Sugiura, Shigeki ^c   Nakamichi, Kazuo ^d   Nukuzuma, Chiyoko ^e   Takegami, Tsutomu ^f  

^a KOBE INSTITUTE OF HEALTH   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e Tokyo SOARA Clinic   (Japan)

^f KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

3 aminobenzamide; IMR 32 cells; JCI cells; PARP 1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 AMINOBENZAMIDE; DIMETHYL SULFOXIDE; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA REPLICATION; DRUG EFFECT; ENZYME ACTIVITY; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; JC VIRUS; NEUROBLASTOMA CELL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; BENZAMIDES; CELL LINE; CELL SURVIVAL; ENZYME INHIBITORS; HUMANS; JC VIRUS; NEURONS; POLY(ADP-RIBOSE) POLYMERASES; STAINING AND LABELING; TETRAZOLIUM SALTS; THIAZOLES; VIRAL LOAD; VIRUS REPLICATION;

JC POLYOMAVIRUS;

EID: 84869205450     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23443     Document Type: Article

References (21)

1. Berger JR, Major EO. 1999. Progressive multifocal leukoencephalopathy. Semin Neurol 19: 193-200.
2. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L. 2009. Identification and characterization of mefloqine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849.
3. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL. 2009. Monoclonal antibody-associated progressive multifocal leukoencephalopathy in patients treated with rituximab, natalizumab and efalizumab: A review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10: 816-824.
4. Chapagain ML, Sumibcay L, Gurjav U, Kaufusi PH, Kast RE, Nerurkar VR. 2008. Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirol 14: 448-454.
5. Clifford DB. 1999. Opportunistic viral infections in the setting of human immunodeficiency virus. Semin Neurol 19: 185-192.
6. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ. 2004. The human polyomavirus JCV, uses serotonin receptors to infect cells. Science 306: 1380-1383.
7. Gordon-Shaag A, Yosef Y, El-Latif MA, Oppenheim A. 2003. The abundant nuclear enzyme PARP participates in the life cycle of Simian virus 40 and is stimulated by minor capsid protein VP3. J Virol 77: 4273-4282.
8. Guidici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Clunque P. 2000. High active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95-99.
9. Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Choen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J. 1998. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Eng J Med 338: 1345-1351.
10. Hirt B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
11. Jeggo PA. 1998. DNA repair: PARP-another guardian angel? Curr Biol 8: R49-R51.
12. Kameoka M, Nukuzuma S, Itaya A, Tanaka Y, Ota K, Ikuta K, Yoshihara K. 2004. RNA interference directed against poly(ADP-ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J Virol 78: 8931-8934.
13. Li Z, Yamauchi Y, Kamakura M, Murayama T, Goshima F, Kimura H, Nishiyama Y. 2012. Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1. J Virol 86: 492-503.
14. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49-73.
15. Marra CM, Rajicic N, Barker DE, Choen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S. 2002. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16: 1791-1797.
16. Nukuzuma S, Yogo Y, Guo J, Nukuzuma C, Itoh S, Shinohara T, Nagashima K. 1995. Establishment and characterization of a carrier cell culture producing high titers of polyoma JC virus. J Med Virol 47: 370-377.
17. Nukuzuma S, Nakamichi K, Nukuzuma C, Takegami T. 2009. Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells. Microbiol Immunol 53: 496-501.
18. Nukuzuma S, Kameoka M, Sugiura S, Nakamichi K, Nukuzuma C, Miyoshi I, Takegami T. 2012. Exogenous human immunodeficiency virus-1 protein, Tat, enhances replication of JC virus efficiently in neuroblastoma cell lines. J Med Virol 84: 555-561.
19. Schaumburg C, O'Hara BA, Lane TE, Atwood WJ. 2008. Human embryonic stem cell-derived oligodendrocyte progenitor cells express the serotonin receptor and are susceptible to JC virus infection. J Virol 8896-8899.
20. Tumiowicz JJ, Nichols WW, Cholon JJ, Greene AE. 1970. Definition of a continous human cell line derived from neruoblastoma. Cancer Res 30: 2110-2118.
21. Yogo Y, Hara K, Guo J, Taguchi F, Nagashima K, Akatani K, Ikegami N. 1993. DNA-sequence rearrangement required for the adaptation of JC polyomavirus to growth in a human neuroblastoma cell line (IMR-32). Virology 197: 793-795.